The Food and Drug Administration on Wednesday granted an emergency use authorization to an at-home COVID-19 test made by German company Siemens Healthineers.
The highly contagious Delta and Omicron coronavirus variants are causing a surge in new cases across the United States, and several retailers, including CVS, Walgreens, and Walmart are limiting the number of at-home testing kits customers can purchase. The Siemens tests are expected to become available in January, and the company said its product can be used by children 2 and up as long as an adult collects the sample.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Today's political cartoons - November 23, 2024Cartoons Saturday's cartoons - qualifications, tax cuts, and more
-
Long summer days in Iceland's highlandsThe Week Recommends While many parts of this volcanic island are barren, there is a 'desolate beauty' to be found in every corner
-
The Democrats: time for wholesale reform?Talking Point In the 'wreckage' of the election, the party must decide how to rebuild
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis usersThe Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
-
ACA opens 2025 enrollment, enters 2024 raceSpeed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
-
McDonald's sued over E. coli linked to burgerSpeed Read The outbreak has sickened at least 49 people in 10 states and left one dead
-
Flame retardants found in black plastics could have health consequencesUnder the Radar Time to replace your kitchen tools
-
Long Covid: study shows damage to brain's 'control centre'The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
-
The 'game-changing' treatment for schizophreniaThe Explainer US poised to approve KarXT as new antipsychotic treatment for disorder, which could offer reduced side-effects
-
The audio industry is working to tackle hearing aid stigmaThe Explainer Only 1 in 5 people who could benefit from hearing aids use them, according to the Hearing Loss Association of America
-
How the brain changes during pregnancyIn The Spotlight 'Baby brain' has some scientific basis but not in the way we first thought
